malondialdehyde has been researched along with dimethylaminomicheliolide in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (100.00) | 2.80 |
Authors | Studies |
---|---|
Che, Y; Feng, X; Guo, X; He, Q; Huang, Z; Liu, Q; Peng, Z; Zhang, S; Zhu, D | 1 |
1 other study(ies) available for malondialdehyde and dimethylaminomicheliolide
Article | Year |
---|---|
Anti-neuroinflammatory effects of dimethylaminomylide (DMAMCL, i.e., ACT001) are associated with attenuating the NLRP3 inflammasome in MPTP-induced Parkinson disease in mice.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Behavior, Animal; Catalase; Circadian Rhythm; Corpus Striatum; Cytokines; Dopaminergic Neurons; Inflammasomes; Inflammation; Malondialdehyde; Mice; NLR Family, Pyrin Domain-Containing 3 Protein; Oxidative Stress; Parkinsonian Disorders; Sesquiterpenes, Guaiane; Substantia Nigra; Superoxide Dismutase; Tyrosine 3-Monooxygenase | 2020 |